AU6605100A - Method and pharmaceutical composition for parenteral administration of iron - Google Patents

Method and pharmaceutical composition for parenteral administration of iron

Info

Publication number
AU6605100A
AU6605100A AU66051/00A AU6605100A AU6605100A AU 6605100 A AU6605100 A AU 6605100A AU 66051/00 A AU66051/00 A AU 66051/00A AU 6605100 A AU6605100 A AU 6605100A AU 6605100 A AU6605100 A AU 6605100A
Authority
AU
Australia
Prior art keywords
iron
pharmaceutical composition
parenteral administration
parenteral
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU66051/00A
Inventor
Ajay Gupta
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU6605100A publication Critical patent/AU6605100A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/295—Iron group metal compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1654—Dialysates therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/28—Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
    • A61M1/287—Dialysates therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU66051/00A 1999-06-30 2000-06-23 Method and pharmaceutical composition for parenteral administration of iron Abandoned AU6605100A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US34564899A 1999-06-30 1999-06-30
US09345648 1999-06-30
PCT/US2000/017311 WO2001000204A1 (en) 1999-06-30 2000-06-23 Method and pharmaceutical composition for parenteral administration of iron

Publications (1)

Publication Number Publication Date
AU6605100A true AU6605100A (en) 2001-01-31

Family

ID=23355895

Family Applications (1)

Application Number Title Priority Date Filing Date
AU66051/00A Abandoned AU6605100A (en) 1999-06-30 2000-06-23 Method and pharmaceutical composition for parenteral administration of iron

Country Status (2)

Country Link
AU (1) AU6605100A (en)
WO (1) WO2001000204A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7670491B2 (en) 1998-10-20 2010-03-02 Advanced Renal Technologies Buffered compositions for dialysis
EP1218039B1 (en) 1999-09-22 2009-02-18 Advanced Renal Technologies Use of high citrate dialysate
SE0400523D0 (en) 2004-03-01 2004-03-01 Gambro Lundia Ab A medical solution, a method for producing said medical solution and use thereof
SE0402507D0 (en) 2004-10-14 2004-10-14 Gambro Lundia Ab Medical solution, method of preparation and use thereof
EP1790356A1 (en) * 2005-11-24 2007-05-30 Vifor (International) Ag Preparation containing iron(III)-complexes and redox substances
DK1973552T3 (en) 2005-12-23 2017-08-07 Ajay Gupta Parenteral nutritional composition containing iron
TWI440457B (en) † 2006-12-12 2014-06-11 Ajinomoto Kk Use of citric acid and/or a citrate salt containing composition
US7816404B2 (en) 2007-07-20 2010-10-19 Rockwell Medical Technologies, Inc. Methods for the preparation and use of ferric pyrophosphate citrate chelate compositions
US20090124572A1 (en) * 2007-11-09 2009-05-14 Deanna Jean Nelson Iron-containing nutritional supplement
CN102159205A (en) 2008-06-25 2011-08-17 Fe3医学有限公司 Patches and methods for the transdermal delivery of a therapeutically effective amount of iron
US8821945B2 (en) 2009-04-25 2014-09-02 Fe3 Medical, Inc. Method for transdermal iontophoretic delivery of chelated agents

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5108767A (en) * 1991-06-10 1992-04-28 Abbott Laboratories Liquid nutritional product for persons receiving renal dialysis
US5906978A (en) * 1996-08-14 1999-05-25 Hemocleanse, Inc. Method for iron delivery to a patient by transfer from dialysate

Also Published As

Publication number Publication date
WO2001000204A1 (en) 2001-01-04

Similar Documents

Publication Publication Date Title
AU4300701A (en) Methods and compositions for administration of therapeutic reagents
AU2319100A (en) Amide derivatives and drug compositions
AU1585601A (en) Transdermal administration of huperzine
HK1131051A1 (en) Pharmaceutical composition of phenofibrate with high bioavailability and method for preparing same
AU7389300A (en) Methods of administration of glycopyrrolate compositions
AU6771500A (en) System and method for administering electronic promotions
AU2001263229A1 (en) Compositions and methods for administration of pharmacologically active compounds
AU6406299A (en) Methods and apparatus for improved administration of pharmaceutically active compounds
HUP0104762A3 (en) Pharmaceutical moxifloxacin compositions and process for their preparation
AU5326100A (en) Pharmaceutical compositions and methods for use
AU4687600A (en) Device and method for the administration of oxygen
AUPP968699A0 (en) Therapeutic compositions and method for their preparation
HUP0202654A3 (en) Pharmaceutical compositions of fibrinolytic agent and process for preparation thereof
AU5336898A (en) Pharmaceutical composition having high bioavailability and method for preparing it
AU5565099A (en) Pharmaceutical compositions and methods for use
AU6605100A (en) Method and pharmaceutical composition for parenteral administration of iron
AU6056500A (en) Process and composition for temporarily suppressing pain
AU3142400A (en) A pharmaceutical composition for treating angiocardiopathy and the method of producing thereof
AU2001230898A1 (en) Formulations and methods for administration of pharmacologically or biologicallyactive compounds
AU4218400A (en) Lyophilized solid dosage forms and methods of making
HUP0204080A3 (en) Novel branched substituted amino derivatives of 3-amino-1-phenyl-1h[1,2,4]triazol, methods for producing them and pharmaceutical compositions containing them
AU2570001A (en) Pharmaceutical composition and method for its manufacture
AU3926000A (en) Methods and compositions for drug delivery
AU4543500A (en) Pharmaceutical compositions and uses
IL144762A0 (en) Liposome composition and method for administration of radiosensitizer

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase